Friday, October 9, 2015: 12:30 PM-2:00 PM
Room: Poster Hall
Learning Objectives:
-
Tracks: Pediatric ID, HIV-STD-TB, Adult ID
Presentations:
Safety and Efficacy of TAF vs. TDF Single-Tablet Regimen in HIV-1 Treatment-Naïve Black and non-Black Patients through Week 48
David Alain Wohl, MD
;
Joseph Gathe, MD
;
Melanie Thompson, MD
;
Robert Grossberg, MD
;
Sorana Segal-Maurer, MD
;
Laurent Cotte, MD
;
Indira Brar, MD
;
Susan Guo, PhD
;
Devi Sengupta, MD
;
Marshall Fordyce, MD
Influence of Age on Outcomes in HIV-infected Adults Initiating Tenofovir Alafenamide Fumarate (TAF) versus Tenofovir Disoproxil Fumarate (TDF) with Elvitegravir, Cobicistat, and Emtricitabine (E/C/F/TAF vs. E/C/F/TDF)
Eric S. Daar, MD
;
Michael Saag, MD, FIDSA
;
Benoit Trottier, M.D.
;
Amanda Clarke, M.D.
;
Edwin Dejesus, MD, FACP, FIDSA
;
David Parks, M.D.
;
Eugenio Teofilo, M.D.
;
Cynthia Brinson, M.D.
;
Hal Martin, M.D., M.P.H.
;
Susan Guo, PhD
;
Sandra Friborg, B.S.
;
Marshall Fordyce, MD
HIV-1 Attachment Inhibitor Prodrug BMS-663068 in Antiretroviral-Experienced Subjects: Week 48 Subgroup Analysis
Judith Feinberg, MD
;
Jacob Lalezari, MD
;
Marcelo Martins, MD
;
Martin Casapia, MD, MPH
;
David Stock, PhD
;
Cyril Llamoso, MD
;
Samit Joshi, DO MPH
;
George Hanna, MD
;
Max Lataillade, DO MPH
CME Credits:
ACPE Credits:
ACPE Number: